<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): May 31, 2000
INSMED INCORPORATED
(Exact name of registrant as specified in its charter)
<TABLE>
<S> <C> <C>
VIRGINIA 0-30739 54-1972729
--------------------------------------------------------------------------------------------
(State or other jurisdiction of (Commission File Number) (I.R.S. Employer
incorporation) Identification No.)
</TABLE>
800 East Leigh Street, Richmond, VA 23219
(Address of principal executive offices and zip code)
Registrant's telephone number, including area code: (804) 828-6893
<PAGE>
ITEM 5. OTHER EVENTS
Press release dated June 1, 2000, issued by Insmed Pharmaceuticals, Inc.
(the "Company"), regarding, among other matters, completion of the
reorganizations of the Company and Celtrix Pharmaceuticals, Inc. into wholly-
owned subsidiaries of the registrant, Insmed Incorporated, is filed herewith as
Exhibit 99 and hereby incorporated in its entirety by reference.
ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS
(c) Exhibit
99 Press Release dated June 1, 2000.
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
INSMED INCORPORATED
Date: June 1, 2000 By: /s/ Michael D. Baer
___________________________
Michael D. Baer
Chief Financial Officer
<PAGE>
INSMED INCORPORATED
INDEX TO EXHIBITS
Exhibit Number
99 Press Release dated June 1, 2000.
